Filter
347
Text search:
GAVI
The
Vaccine
Alliance
Featured
Recommendations
38
New Publications
86
Language
Document type
No document type
132
Studies & Reports
100
Strategic & Response Plan
46
Guidelines
26
Manuals
21
Fact sheets
14
Situation Updates
4
Training Material
2
Brochures
1
Resource Platforms
1
Countries / Regions
Global
50
Liberia
13
Sierra Leone
12
Africa
11
Kenya
9
Nigeria
8
Nepal
6
South–East Asia Region
6
Uganda
5
Zambia
5
Western and Central Europe
5
Guinea
4
Congo, Democratic Republic of
4
Ghana
4
Syria
4
Myanmar / Burma
4
East and Southern Africa
4
West and Central Africa
4
Middle East and North Africa
4
Pakistan
3
South Sudan
3
Bangladesh
3
Malawi
3
Latin America and the Carribbean
3
Asia
3
Burkina Faso
2
Senegal
2
Mali
2
Zimbabwe
2
Afghanistan
2
USA
1
Ethiopia
1
Cameroon
1
India
1
Somalia
1
Iraq
1
Tanzania
1
Cambodia
1
China
1
Rwanda
1
Indonesia
1
South Africa
1
Central African Republic
1
Namibia
1
Brazil
1
Switzerland
1
Ukraine
1
Colombia
1
Lesotho
1
Yemen
1
Eastern Europe and Central Asia
1
Eastern Europe
1
Japan
1
Authors & Publishers
Publication Years
Category
Countries
90
Clinical Guidelines
39
Women & Child Health
26
Public Health
20
Key Resources
10
Capacity Building
3
Pharmacy & Technologies
3
Toolboxes
COVID-19
53
Health Financing Toolbox
44
AMR
18
Rapid Response
15
Ebola & Marburg
14
Global Health Education
14
Polio
10
Malaria
10
Planetary Health
9
2.0 Rapid Response
9
HIV
7
Pharmacy
6
NTDs
6
Cholera
5
Mental Health
5
Conflict
3
Refugee
3
TB
3
Caregiver
3
NCDs
3
Disability
2
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustaina
...
The current SEARVAP (South-East Asia regional vaccine action plan) describes a set of regional goals and objectives for immunization and control of vaccin
...
Long-term polio vaccine security – the timely, sustained, and uninterrupted supply of suitable types of affordable, quality-assured polio vaccines – is essential in
...
This guide is intended to support national governments developing their national deployment and vaccination plans (NDVPs) for COVID-19 vaccines by outlining the roles, needs and opportunities for community health workers (CHWs) to contribute. This n
...
A lack of knowledge about the threat of vaccine-preventable diseases, risks and benefits of vaccines, mistrust of government and health workers, poor service delivery and alternative health or relig
...
Two malaria vaccines are currently WHO prequalified and recommended1 for use to prevent
P. falciparum malaria in young children, the RTS,S/AS01 vaccine, currently manufactured by
GlaxoSmithKline (
...
Available in English, French, Portuguese and Arabic
Successful immunization of a critical mass of the African population with one or several safe and efficacious COVID-19 vaccines.Key objectives1. Accelerate African involvement in
...
For most people in displacement contexts, there are simply not enough vaccines available in the places where they are hosted: 85% of refugees are hosted in lower- and middle-income countries, while in the
...
PHARMA’S RESPONSE TO THE COVID-19 VACCINES CRISIS. Update Feb., 14, 2022. In September 2021, Amnesty International published A Double Dose of Inequality, which assessed the extent to which
...
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in
...
Rivercess, Liberia, April 25, 2024 - Liberia marks a monumental milestone in its battle against malaria
as it launches the highly anticipated RTS,S malaria vaccine today, coinciding with World Mala
...
mnesty International’s annual report on the state of the world’s human rights in 2021, published in March 2022, shows that promises to “build back better” after
...
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of
...
This document is intended to serve as a reference for national public health policy-makers. It outlines the scope of potential meningitis surveillance strategies that make it possible to obtain the
...
Six months after its launch on 24 April, the Access to COVID-19 Tools (ACT) Accelerator has already delivered concrete results in speeding up the development of new therapeutics, diagnostics, and va
...
Presentations and agenda of the meeting held to update industry on the COVAX Facility and Gavi’s support for cold chain equipment (CCE) for COVID
...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available informa
...
L’immunisation: un chantier inachevé
recommended
Un rapport de plaidoyer de la Fédération internationale des Sociétés de la Croix-Rouge et du Croissant-Rouge
publié en partenariat avec l’Alliance mondiale pour les vaccins et l’immunisation (GAV
...
The Guidance on National Deployment and Vaccination Planning is intended to help countries develop their plan for COVID-19 vaccine introduction.
WHO Guideline. Since 2010, countries in the meningitis belt have started to introduce a new serogroup A meningococcal conjugate vaccine conferring individual protection and herd immunity. Following
...
